GST on insulin retains reduced rate under Schedule 1 through the specified deadline, impacting supply classification and compliance obligations. Insulin is classified as goods under Schedule 1 and is subject to GST at 5% until 21-09-2025, establishing a time-limited Schedule-based tax treatment that applies the specified rate for the stated period and ties insulin's supply classification to Schedule 1 while the temporal boundary remains in effect.
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
GST on insulin retains reduced rate under Schedule 1 through the specified deadline, impacting supply classification and compliance obligations.
Insulin is classified as goods under Schedule 1 and is subject to GST at 5% until 21-09-2025, establishing a time-limited Schedule-based tax treatment that applies the specified rate for the stated period and ties insulin's supply classification to Schedule 1 while the temporal boundary remains in effect.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.